Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant

Natalizumab is used as a second-line treatment for multiple sclerosis (MS). Some reports have linked natalizumab to primary central nervous system lymphoma (PCNSL), although few have described its management. A 45-year-old woman with Balo’s Concentric Sclerosis presented dizziness, vertigo accompani...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Karine Moineau-Vallée, Justine Rinfret, My Hanh Luu Hoai, Valérie St-Louis, France Berthelet, Laurent Létourneau-Guillon, Émilie Lemieux-Blanchard, Alexandre Prat, Jean-Philippe Adam
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2020-12-01
Serier:	Current Oncology
Fag:	multiple sclerosis primary central nervous system lymphoma natalizumab autologous hematopoietic stem cell transplant
Online adgang:	https://www.mdpi.com/1718-7729/28/1/22
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!